Skip to content
Smart Money

Pharmaceuticals

GLAXO GlaxoSmithKline Pakistan Limited

Latest results: FY2025 · Dec 2025 Q2 FY2026 · Apr – Jun 2026

Last close · 16 Oct 2026

Rs 312.45 +0.19%

Quarterly · Q3 FY2021 – Q2 FY2026

GlaxoSmithKline Pakistan Limited (GLAXO) quarterly balance sheet

At the end of Q2 FY2026 (Apr – Jun 2026) GlaxoSmithKline Pakistan Limited had total assets of Rs 52.6 bn, up 9.3% on Q2 FY2025. Current assets of Rs 37.1 bn covered current liabilities of Rs 16.3 bn 2.28 times. Total debt was Rs 353.4 mn, leaving net cash of Rs 8.1 bn. Shareholders' equity was Rs 34.4 bn (Rs 108.12 per share), 65.5% of total assets.

GLAXO balance sheet (quarterly) (Rs bn)
Rs bn Q2 FY2026 Apr – Jun 2026 Q1 FY2026 Jan – Mar 2026 Q4 FY2025 Oct – Dec 2025 Q3 FY2025 Jul – Sep 2025 Q2 FY2025 Apr – Jun 2025 Q1 FY2025 Jan – Mar 2025 Q4 FY2024 Oct – Dec 2024 Q3 FY2024 Jul – Sep 2024
Assets
Cash & short-term investments 8.4 9.9 8.6 7.0 6.5 6.2 6.5 6.7
Trade receivables 2.7 3.2 2.8 0.7 0.3 0.6 0.6 0.6
Inventories 15.8 13.2 13.1 17.7 14.5 13.8 11.4 16.0
Total current assets 37.1 38.5 35.2 36.1 33.4 34.1 30.7 33.8
Property, plant & equipment 14.3 14.4 14.4 13.8 13.6 13.6 13.3 12.4
Intangible assets 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0
Other non-current assets 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1
Total non-current assets 15.4 15.5 15.5 14.9 14.7 14.7 14.4 13.5
Total assets 52.6 54.0 50.7 51.0 48.1 48.8 45.1 47.3
Liabilities
Trade payables 4.3 4.1 5.9 5.5 5.2 4.0 5.6 8.4
Short-term borrowings & current portion of debt 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Total current liabilities 16.3 15.9 15.1 19.2 16.7 16.3 14.9 20.1
Long-term debt 0.3 0.3 0.3 0.4 0.3 0.4 0.1 0.1
Other non-current liabilities 0.5 0.7 0.6 0.8 0.7 0.7 0.6 0.7
Total non-current liabilities 1.9 1.8 1.9 2.1 2.1 2.0 1.8 1.9
Total liabilities 18.1 17.7 17.0 21.3 18.8 18.3 16.8 22.0
Equity
Share capital 3.2 3.2 3.2 3.2 3.2 3.2 3.2 3.2
Reserves & retained earnings 31.2 33.1 30.5 26.5 26.1 27.2 25.1 22.1
Equity attributable to shareholders 34.4 36.3 33.7 29.7 29.3 30.4 28.3 25.3
Non-controlling interest 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Total equity 34.4 36.3 33.7 29.7 29.3 30.4 28.3 25.3
Total liabilities & equity 52.6 54.0 50.7 51.0 48.1 48.8 45.1 47.3
Key figures
Total debt 0.4 0.4 0.4 0.4 0.4 0.4 0.2 0.2
Net debt / (net cash) (8.1) (9.6) (8.2) (6.6) (6.2) (5.8) (6.3) (6.5)
Shares outstanding mn 318.5 318.5 318.5 318.5 318.5 318.5 318.5 318.5
Common equity 34.4 36.3 33.7 29.7 29.3 30.4 28.3 25.3
Book value per share (Rs) Rs 108.12 113.94 105.74 93.36 91.96 95.47 88.79 79.31
GLAXO balance sheet — year-on-year change (Rs mn)
Rs mn Q2 FY2026 Apr – Jun 2026 Q1 FY2026 Jan – Mar 2026 Q4 FY2025 Oct – Dec 2025 Q3 FY2025 Jul – Sep 2025 Q2 FY2025 Apr – Jun 2025 Q1 FY2025 Jan – Mar 2025 Q4 FY2024 Oct – Dec 2024 Q3 FY2024 Jul – Sep 2024
Assets
Cash & short-term investments +29.1% +60.2% +31.9% +4.7% +46.0% +101.4% +80.4% +75.0%
Trade receivables +707.1% +401.9% +406.7% +4.6% -54.8% -53.4% -46.0% -39.6%
Inventories +8.7% -4.4% +14.2% +10.2% -3.8% +6.9% -2.9% +20.3%
Total current assets +11.2% +12.9% +14.5% +6.9% +11.2% +26.8% +21.1% +26.0%
Property, plant & equipment +5.3% +6.1% +8.8% +11.8% +11.5% +11.3% +13.3% +10.3%
Intangible assets 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Other non-current assets 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% +50.9%
Total non-current assets +5.0% +5.7% +8.2% +10.7% +10.5% +10.4% +12.2% +9.6%
Total assets +9.3% +10.7% +12.5% +8.0% +11.0% +21.4% +18.2% +20.9%
Liabilities
Trade payables -16.2% +2.8% +5.3% -34.3% -28.4% -36.8% -23.5% +42.4%
Short-term borrowings & current portion of debt +106.6% +74.2% +18.2% -31.1% -51.4% -72.6% -22.4% +100.3%
Total current liabilities -2.7% -2.7% +1.3% -4.2% -7.5% +1.1% +2.5% +18.3%
Long-term debt -6.6% -5.1% +129.9% +143.6% +116.7% +221.9% +25.6% +946.8%
Other non-current liabilities -38.2% -2.8% -3.8% +12.6% +11.4% +7.8% +7.2% +1.4%
Total non-current liabilities -10.9% -9.8% +1.6% +7.8% +8.4% +13.6% -2.3% +30.7%
Total liabilities -3.6% -3.5% +1.4% -3.1% -6.0% +2.4% +2.0% +19.3%
Equity
Share capital 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Reserves & retained earnings +19.7% +21.6% +21.5% +20.3% +29.6% +42.8% +35.7% +26.3%
Equity attributable to shareholders +17.6% +19.3% +19.1% +17.7% +25.5% +36.7% +30.5% +22.2%
Non-controlling interest — — — — — — — —
Total equity +17.6% +19.3% +19.1% +17.7% +25.5% +36.7% +30.5% +22.2%
Total liabilities & equity +9.3% +10.7% +12.5% +8.0% +11.0% +21.4% +18.2% +20.9%
Key figures
Total debt -2.3% -2.5% +112.0% +118.7% +91.6% +137.8% +14.3% +553.5%
Net debt / (net cash) — — — — — — — —
Shares outstanding — — — — — — — —
Common equity +17.6% +19.3% +19.1% +17.7% +25.5% +36.7% +30.5% +22.2%
Book value per share (Rs) +17.6% +19.3% +19.1% +17.7% +25.5% +36.7% +30.5% +22.2%

Change against the same quarter a year earlier; shown when the earlier figure is positive.

GLAXO balance sheet — common size (Rs mn)
Rs mn Q2 FY2026 Apr – Jun 2026 Q1 FY2026 Jan – Mar 2026 Q4 FY2025 Oct – Dec 2025 Q3 FY2025 Jul – Sep 2025 Q2 FY2025 Apr – Jun 2025 Q1 FY2025 Jan – Mar 2025 Q4 FY2024 Oct – Dec 2024 Q3 FY2024 Jul – Sep 2024
Assets
Cash & short-term investments 16.0% 18.4% 17.0% 13.7% 13.6% 12.7% 14.5% 14.2%
Trade receivables 5.1% 5.9% 5.5% 1.3% 0.7% 1.3% 1.2% 1.3%
Inventories 30.0% 24.5% 25.8% 34.6% 30.1% 28.3% 25.4% 34.0%
Total current assets 70.6% 71.3% 69.4% 70.8% 69.4% 69.9% 68.1% 71.5%
Property, plant & equipment 27.3% 26.6% 28.5% 27.1% 28.3% 27.8% 29.4% 26.2%
Intangible assets 1.8% 1.8% 1.9% 1.9% 2.0% 2.0% 2.1% 2.0%
Other non-current assets 0.1% 0.1% 0.1% 0.1% 0.1% 0.1% 0.1% 0.1%
Total non-current assets 29.4% 28.7% 30.6% 29.2% 30.6% 30.1% 31.9% 28.5%
Total assets 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
Liabilities
Trade payables 8.3% 7.6% 11.6% 10.8% 10.8% 8.2% 12.4% 17.7%
Short-term borrowings & current portion of debt 0.1% 0.0% 0.1% 0.0% 0.0% 0.0% 0.1% 0.1%
Total current liabilities 31.0% 29.4% 29.9% 37.6% 34.8% 33.4% 33.1% 42.4%
Long-term debt 0.6% 0.6% 0.7% 0.7% 0.7% 0.7% 0.3% 0.3%
Other non-current liabilities 0.9% 1.2% 1.2% 1.5% 1.5% 1.4% 1.4% 1.5%
Total non-current liabilities 3.5% 3.4% 3.7% 4.1% 4.3% 4.2% 4.1% 4.1%
Total liabilities 34.5% 32.8% 33.6% 41.8% 39.1% 37.6% 37.2% 46.6%
Equity
Share capital 6.1% 5.9% 6.3% 6.2% 6.6% 6.5% 7.1% 6.7%
Reserves & retained earnings 59.4% 61.3% 60.2% 52.0% 54.3% 55.8% 55.7% 46.7%
Equity attributable to shareholders 65.5% 67.2% 66.4% 58.2% 60.9% 62.4% 62.8% 53.4%
Non-controlling interest 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Total equity 65.5% 67.2% 66.4% 58.2% 60.9% 62.4% 62.8% 53.4%
Total liabilities & equity 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
Key figures
Total debt 0.7% 0.7% 0.7% 0.7% 0.8% 0.7% 0.4% 0.4%
Net debt / (net cash) (15.4%) (17.7%) (16.2%) (13.0%) (12.8%) (11.9%) (14.1%) (13.8%)
Common equity 65.5% 67.2% 66.4% 58.2% 60.9% 62.4% 62.8% 53.4%

Each line as a percentage of total assets.

Figures in Pakistani rupees as reported by the company; costs and cash outflows in brackets; "—" = not reported. Updated 16 Oct 2026.

All reported line items 126
GLAXO balance sheet — all reported line items (Rs bn)
Rs bn Q2 FY2026 Apr – Jun 2026 Q1 FY2026 Jan – Mar 2026 Q4 FY2025 Oct – Dec 2025 Q3 FY2025 Jul – Sep 2025 Q2 FY2025 Apr – Jun 2025 Q1 FY2025 Jan – Mar 2025 Q4 FY2024 Oct – Dec 2024 Q3 FY2024 Jul – Sep 2024
Cash & Cash Equivalents 8.4 9.9 8.6 7.0 6.5 6.2 6.5 6.7
Cash & Short Term Investments 8.4 9.9 8.6 7.0 6.5 6.2 6.5 6.7
Short-Term Investments - Total — — — — — — — —
Loans & Receivables - Net - Short-Term 12.7 15.0 13.3 11.2 12.1 13.9 12.6 11.0
Loans & Receivables - Total 12.8 15.1 13.4 11.3 12.1 14.0 12.6 11.1
Trade Accounts & Trade Notes Receivable - Net 2.7 3.2 2.8 0.7 0.3 0.6 0.6 0.6
Loans - Short-Term 2.6 2.1 1.5 2.2 2.2 2.1 1.7 1.2
Income Tax - Receivables - Short-Term 0.2 0.0 — — — — — —
Receivables - Other - Total 7.2 9.7 9.0 8.4 9.5 11.1 10.3 9.1
Inventories - Total 15.8 13.2 13.1 17.7 14.5 13.8 11.4 16.0
Inventories - Raw Materials 7.7 0.3 7.2 0.3 7.1 0.3 5.5 0.2
Inventories - Work in Progress 0.4 — 0.4 — 1.0 — 0.3 —
Inventories - Finished Goods 8.4 12.9 6.7 17.4 7.3 13.5 6.4 15.8
Inventories - Other - Total (0.8) — (1.2) — (0.8) — (0.8) —
Prepaid Expenses - Short-Term 0.3 0.4 0.2 0.2 0.3 0.2 0.2 0.1
Investments - Total — — — — — — — —
Property, Plant & Equipment - Net - Total 14.3 14.4 14.4 13.8 13.6 13.6 13.3 12.4
Other Assets - Total 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1
Intangible Assets - Total - Net 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0
Total Current Assets 37.1 38.5 35.2 36.1 33.4 34.1 30.7 33.8
Intangible Assets - excluding Goodwill - Net - Total — — — — — — — —
Goodwill/Cost in Excess of Assets Purchased - Net — — 1.0 — — — 1.0 —
Receivables & Loans - Long-Term 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1
Loans - Long-Term 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1
Property, Plant & Equipment - excluding Assets Leased Out - Net - Total 14.3 14.4 14.4 13.8 13.6 13.6 13.3 12.4
Plant, Machinery & Equipment - Net 0.3 0.2 0.3 0.3 0.3 0.3 0.3 2.0
Construction in Progress - Net 2.9 3.5 3.3 2.6 2.5 2.5 3.1 0.2
Right of Use Tangible Assets - Total - Net 0.3 0.3 0.3 0.3 0.3 0.3 0.2 0.2
Right of Use Tangible Assets - Capital/Finance Lease - Net 0.3 0.3 0.3 0.3 0.3 0.3 0.2 0.2
Property, Plant & Equipment - Other - Net 10.8 10.4 10.5 10.6 10.4 10.3 9.8 10.0
Total Assets 52.6 54.0 50.7 51.0 48.1 48.8 45.1 47.3
Debt - Total 0.4 0.4 0.4 0.4 0.4 0.4 0.2 0.2
Short-Term Debt & Current Portion of Long-Term Debt 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Current Portion of Long-Term Debt including Capitalized Leases 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Capitalized Leases - Current Portion 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Debt - Long-Term - Total 0.3 0.3 0.3 0.4 0.3 0.4 0.1 0.1
Assets Held for Sale/Discontinued Operations - Long-Term — — — — — — — —
Capitalized Lease Obligations - Long-Term 0.3 0.3 0.3 0.4 0.3 0.4 0.1 0.1
Other Non-Current Assets - Total 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1
Dividends Payable 0.2 0.2 0.2 0.2 0.2 0.1 0.1 0.1
Deferred Tax & Investment Tax Credits - Long-Term 1.1 0.9 0.9 1.0 1.0 1.0 1.1 1.1
Deferred Tax - Liability - Long-Term 1.1 0.9 0.9 1.0 1.0 1.0 1.1 1.1
Payables & Accrued Expenses 9.4 9.7 11.7 12.4 10.5 9.2 11.0 14.5
Trade Account Payables - Total 4.3 4.1 5.9 5.5 5.2 4.0 5.6 8.4
Other Non-Current Assets 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1
Accrued Expenses 5.1 5.6 5.8 6.9 5.3 5.2 5.4 6.1
Licenses, Franchises, Copyrights, Property Rights, Prototypes, Contract Based, Models & Designs - Net — — — — — — — —
Total Liabilities 18.1 17.7 17.0 21.3 18.8 18.3 16.8 22.0
Shareholders' Equity - Attributable to Parent Shareholders - Total 34.4 36.3 33.7 29.7 29.3 30.4 28.3 25.3
Total Non-Current Assets 15.4 15.5 15.5 14.9 14.7 14.7 14.4 13.5
Common Equity Attributable to Parent Shareholders 34.4 36.3 33.7 29.7 29.3 30.4 28.3 25.3
Common Equity - Contributed 3.2 3.2 3.2 3.2 3.2 3.2 3.2 3.2
Common Stock - Issued & Paid 3.2 3.2 3.2 3.2 3.2 3.2 3.2 3.2
Equity - Non-Contributed - Reserves & Retained Earnings 31.2 33.1 30.5 26.5 26.1 27.2 25.1 22.1
Retained Earnings - Total 27.2 33.1 26.5 22.5 22.1 27.2 21.1 18.1
Trade Accounts Payable & Accruals - Short-Term 9.4 9.7 11.7 12.4 10.5 9.2 11.0 14.5
Trade Accounts & Trade Notes Payable - Short-Term 4.3 4.1 5.9 5.5 5.2 4.0 5.6 8.4
Accrued Expenses - Short-Term 5.1 5.6 5.8 6.9 5.3 5.2 5.4 6.1
Other Reserves/Equity - Total 4.0 — 4.0 4.0 4.0 — 4.0 4.0
Income Taxes - Payable - Short-Term 0.0 0.0 1.0 1.2 1.2 1.9 1.4 0.8
Dividends/Distributions Payable 0.2 0.2 0.2 0.2 0.2 0.1 0.1 0.1
Other Current Liabilities - Total 6.6 6.0 2.3 5.4 4.9 5.0 2.4 4.6
Common Equity - Total 34.4 36.3 33.7 29.7 29.3 30.4 28.3 25.3
Deferred Income - Short-Term 2.4 — 1.8 2.2 1.8 — 2.0 2.2
Total Shareholders' Equity - including Minority Interest & Hybrid Debt 34.4 36.3 33.7 29.7 29.3 30.4 28.3 25.3
Total Liabilities & Equity 52.6 54.0 50.7 51.0 48.1 48.8 45.1 47.3
Provisions - Short-Term 0.2 0.2 0.2 0.2 0.2 0.1 0.2 0.1
Other Current Liabilities 4.0 5.8 0.3 3.0 2.9 4.8 0.2 2.2
Total Current Liabilities 16.3 15.9 15.1 19.2 16.7 16.3 14.9 20.1
Other Non-Current Liabilities - Total 0.5 0.7 0.6 0.8 0.7 0.7 0.6 0.7
Provisions - Long-Term 0.5 0.7 0.6 0.8 0.7 0.7 0.6 0.7
Post Employment Benefits - Pension & Other - Long-Term 0.5 0.7 0.6 0.8 0.7 0.7 0.6 0.7
Total Non-Current Liabilities 1.9 1.8 1.9 2.1 2.1 2.0 1.8 1.9
Common Shares - Issued - Total mn 318.5 318.5 318.5 318.5 318.5 318.5 318.5 318.5
Common Shares - Outstanding - Total mn 318.5 318.5 318.5 318.5 318.5 318.5 318.5 318.5
Common Shares - Treasury - Total mn 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Common Shares - Authorized - Issue Specific mn — — 500.0 — — — 500.0 —
Common Shares - Issued - Issue Specific mn 318.5 318.5 318.5 318.5 318.5 318.5 318.5 318.5
Common Shares - Outstanding - Issue Specific mn 318.5 318.5 318.5 318.5 318.5 318.5 318.5 318.5
Common Shares - Treasury - Issue Specific mn 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Asset Allocation Factor - Issue Specific 1.00× 1.00× 1.00× 1.00× 1.00× 1.00× 1.00× 1.00×
Right of Use Tangible Assets - Total - Net - Supplemental 0.3 0.3 0.3 0.3 0.3 0.3 0.2 0.2
Right of Use Tangible Assets - Capital/Finance Lease - Net - Supplemental 0.3 0.3 0.3 0.3 0.3 0.3 0.2 0.2
Property, Plant & Equipment - excluding Right of Use Tangible Assets & Capital Leases - Net - Supplemental 14.0 14.1 14.1 13.5 13.3 13.2 13.1 12.2
Finance and Operating Lease Liabilities - Total - Supplemental 0.4 0.4 0.4 0.4 0.4 0.4 0.2 0.2
Debt including Finance and Operating Lease Liabilities - Supplemental 0.4 0.4 0.4 0.4 0.4 0.4 0.2 0.2
Net Debt (8.1) (9.6) (8.2) (6.6) (6.2) (5.8) (6.3) (6.5)
Asset Accruals 44.1 44.0 41.0 44.0 41.5 42.5 37.5 40.5
Cash & Cash Equivalents - Total 8.4 9.9 8.6 7.0 6.5 6.2 6.5 6.7
Cash & Short Term Investments - Total 8.4 9.9 8.6 7.0 6.5 6.2 6.5 6.7
Debt - including Preferred Equity & Minority Interest - Total 0.4 0.4 0.4 0.4 0.4 0.4 0.2 0.2
Net Book Capital 26.4 26.7 25.5 23.1 23.1 24.6 21.9 18.7
Net Operating Assets 26.4 26.7 25.5 23.1 23.1 24.6 21.9 18.7
Provisions - Total 1.8 1.7 1.7 2.0 1.9 1.8 1.9 1.9
Shareholders Equity - Common 34.4 36.3 33.7 29.7 29.3 30.4 28.3 25.3
Tangible Total Equity 33.5 35.3 32.7 28.8 28.3 29.4 27.3 24.3
Tangible Book Value 33.5 35.3 32.7 28.8 28.3 29.4 27.3 24.3
Total Book Capital 34.8 36.6 34.0 30.1 29.6 30.8 28.5 25.4
Total Capital 34.8 36.6 34.0 30.1 29.6 30.8 28.5 25.4
Total Long Term Capital 36.3 38.1 35.5 31.8 31.4 32.5 30.1 27.2
Unearned Revenue - Total 2.4 — 1.8 2.2 1.8 — 2.0 2.2
Book Value excluding Other Equity 30.4 36.3 29.7 25.7 25.3 30.4 24.3 21.3
Assets Held for Sale/Discontinued Operations - Long-Term & Short-Term — — — — — — — —
Income Taxes - Payable - Long-Term & Short-Term 0.0 0.0 1.0 1.2 1.2 1.9 1.4 0.8
Revolving Line of Credit - Unutilized/Unused Amount — — — — — — — —
Revolving Line of Credit - Total Principal Amount — — — — — — — —
Contract Liabilities - Short-Term - Advance Consideration & Progress Billings in Excess of Unbilled Revenue 2.4 — 1.8 2.2 1.8 — 2.0 2.2
Accruals - Short-Term 12.4 12.7 11.4 9.9 10.2 11.6 9.3 7.0
Cash & Short Term Investments - Net of Debt 8.1 9.6 8.2 6.6 6.2 5.8 6.3 6.5
Current Portion of Long-Term Debt including Capitalized Leases & Hybrid Financial Instruments 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Total Fixed Assets - Net 15.3 15.4 14.5 14.8 14.6 14.6 13.3 13.4
Working Capital 20.9 22.6 20.0 16.9 16.7 17.8 15.8 13.7
Interest Bearing Liabilities - Total 0.4 0.4 0.4 0.4 0.4 0.4 0.2 0.2
Working Capital - Non-Cash 12.4 12.7 11.4 9.9 10.2 11.6 9.3 7.0
Working Capital excluding Other Current Assets & Liabilities 27.5 28.7 22.3 22.3 21.6 22.8 18.1 18.3
Net Debt Including Preferred Equity & Minority Interest (8.1) (9.6) (8.2) (6.6) (6.2) (5.8) (6.3) (6.5)
Other Short-Term & Long-Term Assets - Total 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1
Other Short-Term & Long-Term Liabilities - Total 6.6 6.0 2.3 5.4 4.9 5.0 2.4 4.6
Total Current Assets excluding Total Inventories 21.4 25.3 22.1 18.4 18.9 20.3 19.3 17.7
Tangible Book Value excluding Other Equity 29.5 35.3 28.7 24.8 24.3 29.4 23.3 20.3
Total Debt Excluding Islamic 0.4 0.4 0.4 0.4 0.4 0.4 0.2 0.2
Trade Accounts & Trade Notes Receivable - Net - Total 2.7 3.2 2.8 0.7 0.3 0.6 0.6 0.6
Current Liabilities excluding Current Debt - Total 16.3 15.8 15.1 19.2 16.7 16.3 14.9 20.0
Cash in Hand & with Banks - Total 8.4 9.9 8.6 7.0 6.5 6.2 6.5 6.7
Current Assets excluding Cash & Short Term Investments - Total 28.7 28.6 26.6 29.1 26.9 27.9 24.2 27.1
Cash, Short Term Investments & Accounts Receivable - Total 11.1 13.1 11.4 7.7 6.9 6.8 7.1 7.3

Every line the company reported, in the original order and wording, without regrouping or signs changed.